| Market Cap | €4.9M | |
| Enterprise Value | — | |
| Revenue | €12.99B | +4.5% |
| Gross Profit | €1.76B | +4.3% |
| EBITDA | €491.6M | +9.0% |
| Net Income | €308.2M | +13.2% |
| Diluted EPS | — | — |
| Free Cash Flow | €358.6M | +31.9% |
| DPS (FY2024) | — |
| Trailing yield | — |
| Payout ratio | 82.2% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20242024-09-30 | — | — | reported |
| FY20232023-09-30 | — | — | reported |
| FY20222022-09-30 | — | — | reported |
| FY20212021-09-30 | — | — | reported |
| Ratio | 2021 | 2022 | 2023 | 2024 | Trend · 4y | vs own | vs sector |
|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||
| Gross Margin | 10.90% | 10.78% | 13.55% | 13.53% | 63% | 13% | |
| Operating Margin | 2.22% | 2.32% | 2.36% | 2.51% | 88% | 33% | |
| EBITDA Margin | 3.37% | 3.40% | 3.63% | 3.79% | 88% | 25% | |
| NOPAT Margin | 1.65% | 1.71% | 1.75% | 1.85% | 88% | 31% | |
| Net Margin | 1.61% | 1.73% | 2.19% | 2.37% | 88% | 40% | |
| FCF Margin | −3.09% | 5.36% | 2.19% | 2.76% | 63% | 36% | |
| FCFF Margin | −3.07% | 5.37% | 2.24% | 2.82% | 63% | 18% | |
| OCF Margin | −2.79% | 5.61% | 2.48% | 3.06% | 63% | 26% | |
| Gross Profitability | 15.55% | 16.05% | 20.89% | 21.74% | 88% | 49% | |
| Capex Intensity | 0.29% | 0.25% | 0.29% | 0.30% | 88% | 10% | |
| ▸Returns on Capital · 2 ratios | |||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||
| ▸Earnings quality · 6 ratios | |||||||
| ▸Liquidity & coverage · 3 ratios | |||||||
| ▸Working capital · 7 ratios | |||||||
| ▸Capital allocation · 5 ratios | |||||||
| ▸Other · 1 ratios | |||||||
The five drivers multiply to 48.1% vs reported ROE 50.0%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | €10.82B | €11.46B | €12.43B | €12.99B |
| YoY % | +6.0% | +8.4% | +4.5% | |
| Cost of Revenue | €9.64B | €10.23B | €10.74B | €11.23B |
| YoY % | +6.1% | +5.0% | +4.5% | |
| Gross Profit | €1.18B | €1.24B | €1.68B | €1.76B |
| YoY % | +4.7% | +36.3% | +4.3% | |
| R&D Expense | €2.5M | €1.9M | €2.1M | €1.8M |
| YoY % | -24.7% | +11.4% | -15.7% | |
| Operating Income | €240.3M | €266.4M | €293.3M | €326.2M |
| YoY % | +10.9% | +10.1% | +11.2% | |
| Interest Expense | €1.7M | €2.4M | €8.1M | €10.2M |
| YoY % | +39.8% | +233.7% | +26.0% | |
| Interest & Investment Income | €21.9M | €21.6M | €84.3M | €103.2M |
| YoY % | -1.6% | +290.6% | +22.4% | |
| Equity Method Income | €2.2M | €2.8M | €2.6M | €1.4M |
| YoY % | +25.3% | -7.2% | -46.9% | |
| Pretax Income | €260.5M | €285.6M | €369.5M | €419.2M |
| YoY % | +9.6% | +29.4% | +13.5% | |
| Income Tax | €67.3M | €75.0M | €95.7M | €110.9M |
| YoY % | +11.3% | +27.7% | +15.8% | |
| Income from Continuing Operations | €193.2M | €210.6M | €273.8M | €308.3M |
| YoY % | +9.0% | +30.0% | +12.6% | |
| Income from Discontinued Operations | -€19.1M | -€11.5M | €0 | €0 |
| Net Income (incl. NCI) | €174.1M | €199.1M | €273.8M | €308.3M |
| YoY % | +14.4% | +37.5% | +12.6% | |
| Minority Interest (P&L) | €183,000 | €299,000 | €1.5M | €62,000 |
| YoY % | +63.4% | +403.3% | -95.9% | |
| Net Income | €174.0M | €198.8M | €272.3M | €308.2M |
| YoY % | +14.3% | +36.9% | +13.2% | |
| EPS (Basic) | €1.32 | €1.51 | €2070.00 | €2340.00 |
| YoY % | +14.4% | +136986.1% | +13.0% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
